<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318056</url>
  </required_header>
  <id_info>
    <org_study_id>ABR-SIUSOM-14-002</org_study_id>
    <nct_id>NCT02318056</nct_id>
  </id_info>
  <brief_title>The Burn Glove Trial - Hand Burn Dressing Pilot</brief_title>
  <official_title>The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Illinois University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Illinois University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Specific Aim 1: To determine if one of three burn dressings provides a less painful healing&#xD;
      experience for partial thickness hand.&#xD;
&#xD;
      Specific Aim 2: To evaluate if one of three dressings provides greater functionality during&#xD;
      and after healing of partial thickness hand burns.&#xD;
&#xD;
      Specific Aim 3: To determine if one of three burn dressings promotes aesthetically superior&#xD;
      healing results for partial thickness hand burns.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Various products are on the market and available for use on partial thickness burns to the&#xD;
      hand/s. Our current institutional standard of care is to use Xeroform Gauze (Coviden,&#xD;
      Mansfield, MA) and Bacitracin Ointment (Fougera, Melville, NY) to promote a moist&#xD;
      antibacterial healing environment with the ability to monitor the healing progress daily.&#xD;
      However, silver (AG) based dressings that employ nanocrystalline technology with hydrofiber&#xD;
      (Aquacel AG burn; ConvaTec, Princeton, NJ) or soft silicone foam (Mepilex AG ; Molnlycke&#xD;
      Health Care, Dunstable, United Kingdom) have been well accepted as alternative dressing&#xD;
      solutions. These dressings have longer interval times between changes, leading to a reported&#xD;
      increase in patient comfort, diminished skin shearing/stripping, and rapid&#xD;
      re-epithelialization.&#xD;
&#xD;
      Given the anatomic intricacies, partial thickness burns to the hand present a challenge in&#xD;
      dressing selection. Recently, ConvaTec unveiled the Aquacel AG Burn Glove for use on partial&#xD;
      thickness hand burns. In line with this idea, our institution has now begun to fashion a&#xD;
      novel burn glove out of Mepilex Transfer AG with good success. To date there are no known&#xD;
      studies that compare Xeroform/Bacitracin, Aquacel AG burn glove or Mepilex Transfer AG&#xD;
      dressing. The goal of this study is to compare these three burn dressings used to treat&#xD;
      partial-thickness hand burns and their impact on pain, function, and aesthetic outcomes. We&#xD;
      will also explore psychosocial issues related to hand burn dressing changes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Due to reorganization.&#xD;
  </why_stopped>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>pain as measured by the Patient and Provider Scar Assessment Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>pain as measured by the Michigan Hand Outcomes Questionnaire (MHQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>pain as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functionality</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>functionality as measured by the Michigan Hand Outcomes Questionnaire (MHQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functionality</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>functionality as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aesthetic appearance</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>scar formation and aesthetic appearance measured using the Vancouver Scar Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aesthetic appearance</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>scar formation and aesthetic appearance measured using the the Patient and Provider Scar Assessment Scale</description>
  </secondary_outcome>
  <other_outcome>
    <measure>quality of life</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>quality of life measured by the psychosocial scales: Burn Specific Health Scale (BSHS)</description>
  </other_outcome>
  <other_outcome>
    <measure>resilience</measure>
    <time_frame>baseline to 6 months post-burn injury</time_frame>
    <description>resilience measured by the Connor-Davidson Resilience Scale (CD-RISC)</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Aquacel® Ag Burn Glove</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of Aquacel® Ag Burn Glove burn dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepilex® Transfer Ag</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Mepilex® Transfer Ag burn dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xeroform®/Bacitracin®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Xeroform® burn dressing and Bacitracin® topical antibiotic</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aquacel® Ag Burn Glove</intervention_name>
    <description>burn dressing</description>
    <arm_group_label>Aquacel® Ag Burn Glove</arm_group_label>
    <other_name>ConvaTec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mepilex® Transfer Ag</intervention_name>
    <description>burn dressing</description>
    <arm_group_label>Mepilex® Transfer Ag</arm_group_label>
    <other_name>Safetac®</other_name>
    <other_name>Molnlycke® Health Care</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>antibiotic</intervention_name>
    <description>antibiotic burn dressing</description>
    <arm_group_label>Xeroform®/Bacitracin®</arm_group_label>
    <other_name>Bacitracin®</other_name>
    <other_name>Xeroform®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting at Memorial Medical or Southern Illinois University (SIU) Health&#xD;
             Care&#xD;
&#xD;
          -  Patients with partial-thickness burn injuries to the dorsum and/or palm of the hand/s&#xD;
             that exceeds ½% total body surface area (TBSA) for at least one hand.&#xD;
&#xD;
          -  &lt; 10% TBSA 2nd and 3rd degree burn injuries&#xD;
&#xD;
          -  Initial clinical presentation &lt; 5 days post burn injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; ½ % TBSA involving the hand&#xD;
&#xD;
          -  &gt; 10%TBSA burn injuries&#xD;
&#xD;
          -  &gt; 60 years of age&#xD;
&#xD;
          -  &lt; 8 years of age&#xD;
&#xD;
          -  Patients (or parents of minors) without cognitive capacity to comprehend informed&#xD;
             consent&#xD;
&#xD;
          -  Presentation &gt; 5 days post-burn injury event&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Full thickness/3rd degree burns to the dorsal and/or palmer hand/s&#xD;
&#xD;
          -  Exposed vital structures (tendons, nerves, bone, vessels)&#xD;
&#xD;
          -  Uncontrolled Type II Diabetes&#xD;
&#xD;
          -  Type I Diabetes&#xD;
&#xD;
          -  History of Chronic Obstructive Pulmonary Disease&#xD;
&#xD;
          -  Have a known allergy to silver products&#xD;
&#xD;
          -  Signs of infection on initial clinical presentation (presence of purulent drainage,&#xD;
             significant cellulitis, and/or fever)&#xD;
&#xD;
          -  Smoke/inhalation injuries requiring ventilation&#xD;
&#xD;
          -  Critically ill patients requiring intensive care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nada N Berry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Illinois University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern Illinois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62794-9640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.siumed.edu/surgery/plastics/clinical-research.html</url>
    <description>Institute for Plastic Surgery, Office for Clinical Research</description>
  </link>
  <reference>
    <citation>Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD002106. doi: 10.1002/14651858.CD002106.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD002106.</citation>
    <PMID>18843629</PMID>
  </reference>
  <reference>
    <citation>Robson MC, Smith DJ Jr, VanderZee AJ, Roberts L. Making the burned hand functional. Clin Plast Surg. 1992 Jul;19(3):663-71. Review.</citation>
    <PMID>1633673</PMID>
  </reference>
  <reference>
    <citation>Kamolz LP, Kitzinger HB, Karle B, Frey M. The treatment of hand burns. Burns. 2009 May;35(3):327-37. doi: 10.1016/j.burns.2008.08.004. Epub 2008 Oct 25. Review.</citation>
    <PMID>18952379</PMID>
  </reference>
  <reference>
    <citation>Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res. 2009 Sep;67(3):253-71. doi: 10.1016/j.jpsychores.2009.04.002. Epub 2009 Jul 2. Review.</citation>
    <PMID>19686881</PMID>
  </reference>
  <reference>
    <citation>Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007 Mar;33(2):139-48. Epub 2006 Nov 29. Review.</citation>
    <PMID>17137719</PMID>
  </reference>
  <reference>
    <citation>Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol. 1996 May;26(3):255-60. Review.</citation>
    <PMID>8726163</PMID>
  </reference>
  <reference>
    <citation>Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004 Mar-Apr;25(2):192-6.</citation>
    <PMID>15091147</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 23, 2014</study_first_submitted>
  <study_first_submitted_qc>December 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>July 20, 2016</last_update_submitted>
  <last_update_submitted_qc>July 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hand</keyword>
  <keyword>burns</keyword>
  <keyword>thermal</keyword>
  <keyword>dressing</keyword>
  <keyword>Aquacel®</keyword>
  <keyword>Mepilex® Transfer Ag</keyword>
  <keyword>Xeroform®</keyword>
  <keyword>Bacitracin®</keyword>
  <keyword>partial thickness</keyword>
  <keyword>epithelialization</keyword>
  <keyword>wound healing</keyword>
  <keyword>scar</keyword>
  <keyword>scarring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Bacitracin</mesh_term>
    <mesh_term>Carboxymethylcellulose Sodium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

